Article info
PDFClinical and epidemiological research
Concise report
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
- Correspondence to Professor Christopher P Denton, Centre for Rheumatology, UCL Division of Medicine, Rowland Hill Street, London NW3 2PF, UK; c.denton{at}ucl.ac.uk
Citation
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
Publication history
- Received December 24, 2015
- Revised July 1, 2016
- Accepted July 3, 2016
- First published July 25, 2016.
Online issue publication
October 31, 2019
Article Versions
- Previous version (2 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/